CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
53 hedge funds and large institutions have $58M invested in Concert Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
24
Closed
8
Calls
$54K
Puts
$56K
Net Calls
-$2K
Net Calls Change
-$85K
Top Buyers
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$2.96M |
| 2 |
2
Morgan Stanley
New York
|
$229K |
| 3 |
3
Renaissance Technologies
New York
|
$1.44M |
| 4 |
4
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$108K |
| 5 |
5
Millennium Management
New York
|
$4.2M |
